Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010.
about
Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillationAre Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European CountriesCost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgeryPatient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death.The Relative Impacts of Disease on Health Status and Capability Wellbeing: A Multi-Country Study.Examining the relationship between health-related quality of life and increasing numbers of diagnoses.Assessing the validity of the ICECAP-A capability measure for adults with depression.A Framework for Including Family Health Spillovers in Economic Evaluation.Influenced from the start: anchoring bias in time trade-off valuations.Preventing postnatal maternal mental health problems using a psychoeducational intervention: the cost-effectiveness of What Were We Thinking.More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model.Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trialCondition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.Study Comparing Vein Integrity and Clinical Outcomes in Open Vein Harvesting and 2 Types of Endoscopic Vein Harvesting for Coronary Artery Bypass Grafting: The VICO Randomized Clinical Trial (Vein Integrity and Clinical Outcomes).Multiple treatment comparison of seven new drugs for patients with advanced malignant melanoma: a systematic review and health economic decision model in a Norwegian setting.Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial.Health-related quality of life as measured by the EQ-5D in the prevention, screening and management of cervical disease: A systematic review.Recovery after cataract surgery.Health-state utility estimates for health technology assessment: a review of the manufacturers' submissions to the French National Authority for Health.Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product Approval.Cost-effectiveness of implant-supported mandibular removable partial dentures.Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation.Health-related quality of life after cataract surgery with the phacoemulsification technique and intraocular lens implantation.Cost effectiveness of an intervention focused on reducing bathing disability.Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY.Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial.Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas.In search of a common currency: A comparison of seven EQ-5D-5L value sets.Quantifying the Relationship between Capability and Health in Older People: Can't Map, Won't Map.Choice of Outcome Measure in an Economic Evaluation: A Potential Role for the Capability Approach.Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese.Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway.Comparing and transforming PROMIS utility values to the EQ-5D.Age- and sex-specific Canadian utility norms, based on the 2013-2014 Canadian Community Health Survey.A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models.A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis.Assessment of outcome measures for cost-utility analysis in depression: mapping depression scales onto the EQ-5D-5L.General population norms for the EQ-5D-3 L in Norway: comparison of postal and web surveys
P2860
Q33651588-5A19441A-8C63-4069-ADDA-7EAF17EBB8AFQ33665428-1877F903-820A-4432-ADB4-B2F3ABDED159Q33665611-CC1F1C35-F5BD-443B-9234-8542FAB7E2ECQ33828725-A7B254CE-E903-4F6F-A6B2-F1E228EACAFAQ34235050-7BDA2C69-7874-47FB-AEFB-7E27331317B2Q35858768-779B98B0-8A6F-433F-B3F8-C8C9E3256E62Q36191351-5900D087-DB64-444F-9EE6-FDCEF92BDF9AQ36266693-B089D0AF-51FE-402A-9299-C166CDD73EC6Q36451238-88732D9C-1D3B-49CA-BB7C-0F8F85F38C60Q37166059-5BD81683-F960-4F56-B606-A75A70FBFD34Q37454031-FFBC9B00-4246-458A-9286-BB2F9B936D0DQ37559879-42167AC0-2AB4-48E1-88B9-A5E14A651C3DQ37620096-8A11EA5F-E73C-4D99-8780-B022533D9F68Q37733475-D262B600-1DE4-436B-8C9F-CFDA8B90D88FQ38375201-75B97943-D6CB-492B-9CF3-CFFE6061ADFDQ38615575-5BCE725B-5A63-40D2-A63D-DBC8385F62B6Q38685820-0021AD74-0ECB-4E2F-A5BA-34B3111CB851Q38707755-161FB540-CFC2-47DA-A327-655244270DCFQ38816679-D4C648CB-8DEA-433A-BF69-A0C30E386186Q39108852-DF75A821-E7E5-482B-AB64-559C573A671CQ39198395-2409D62C-45BF-4CDB-A914-BC99E7FF6748Q40799527-D62772FA-1199-4AB7-BF1A-226F87E4F697Q40859615-6F66ACFE-553C-486A-A1E9-72D3256A5355Q40938464-323DC9C8-1BEA-4E3D-AE97-6BF0836D2931Q41636128-3A38C4A7-12EA-4737-843F-EFC4BF9E62C1Q42634687-0F24B18D-AFFE-4580-B2F9-122B5DD808C6Q47112566-14988998-675D-4B28-B8F1-2EA9B01046A5Q47569275-ECB833E0-7EDC-486A-B5AE-B32C8D71A3F4Q47732157-11B631CE-3228-4C25-8E0E-BF4BB9B77AFBQ47732575-D450D235-D80C-4209-A162-8ACE9FAF8386Q48041192-346D984D-EA6C-4775-9666-4CB3F31FD6D7Q48064486-4F0B5150-0031-451A-8E00-1851B332D777Q48111916-46B0560C-5EAA-423C-BE43-CA96438F017EQ48372464-F4285253-2285-425C-8AAC-A263000EC9F5Q49765609-71FABF70-76DA-4B66-B742-B2D262E7CDBAQ50100243-A78B96F8-7D2F-4F7B-A761-B9BB56BB501AQ50111623-C31A05AC-043E-41A3-8B26-E3455706B22FQ55508130-DC058F8F-F762-4729-B294-3733FDC2DBB0Q57810125-7820EC9F-EAF9-46A9-833C-934EB356E8EF
P2860
Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Estimating QALY gains in appli ...... ty analyses published in 2010.
@en
Estimating QALY gains in appli ...... ty analyses published in 2010.
@nl
type
label
Estimating QALY gains in appli ...... ty analyses published in 2010.
@en
Estimating QALY gains in appli ...... ty analyses published in 2010.
@nl
prefLabel
Estimating QALY gains in appli ...... ty analyses published in 2010.
@en
Estimating QALY gains in appli ...... ty analyses published in 2010.
@nl
P2093
P2860
P1433
P1476
Estimating QALY gains in appli ...... ty analyses published in 2010.
@en
P2093
Espen Movik
Gunhild Hagen
Jan Abel Olsen
Marianne Klemp
Torbjørn Wisløff
Vida Hamidi
P2860
P2888
P304
P356
10.1007/S40273-014-0136-Z
P577
2014-04-01T00:00:00Z